Dear Doctor - Participate in the Survey on thromboprophylaxis " A recent survey of patients with thrombophilia found that most patients are not receiving adequate thromboprophylaxis. Thrombophilia is a condition that predisposes patients to developing blood clots, and thromboprophylaxis is the use of medication or other interventions to prevent blood clots from forming.The survey found that only 43% of patients with thrombophilia were receiving anticoagulant medication, which is the most effective form of thromboprophylaxis. This means that the majority of patients with thrombophilia are not being adequately protected from developing blood clots.There are several reasons why patients with thrombophilia may not be receiving appropriate thromboprophylaxis. First, many patients are not aware that they have thrombophilia. Second, even when patients are aware of their condition, they may not be aware of the importance of using anticoagulants or other forms of thromboprophylaxis. Third, some patients may be reluctant to take anticoagulants because of the potential side effects. Finally, some physicians may not be familiar with the latest guidelines for managing thrombophilia and therefore may not be prescribing anticoagulants to their patients with this condition.The results of this survey underscore the need for better education for both patients and physicians about thrombophilia . Participate in Surveys "
1.
Examines Office-Based Transperineal Prostate Biopsies Methodology.
2.
Patients value communication skills from cancer surgeons across six key areas, according to research
3.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
4.
Underprescribed for Alcohol Use Disorder is pharmacotherapy.
5.
A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma
1.
Transfusing the Future: Exploring the Possibilities of Blood Transfusions
2.
Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications
3.
Iron Deficiency Anemia: Challenges in Diagnosis and Treatment
4.
Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers
5.
The Potential of Amifostine in Cancer Treatment: A Revolutionary Breakthrough
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
2.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
3.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
4.
Updates on the First Line Management of ALK+ NSCLC
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation